Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.7569
-0.0425 (-5.32%)
At close: Jun 27, 2025, 4:00 PM
0.7947
+0.0378 (4.99%)
After-hours: Jun 27, 2025, 7:46 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $122.43 million as of June 27, 2025. Its market cap has decreased by -92.09% in one year.
Market Cap
122.43M
Enterprise Value
-125.99M
1-Year Change
-92.09%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $122.43M, a decrease of -95.26%. That is a compound annual growth rate of -82.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 126.16M | -92.63% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |